1. Rackham Alumnus Receives Award for Cancer Breakthrough

Rackham Alumnus Receives Award for Cancer Breakthrough

Arul Chinnaiyan was recognized for his identification of a gene fusion that drives prostate cancer.

April 2, 2026 | Rackham Graduate School

Categories:

A man in a checked suit jacket and light blue shirt stands indoors, with a blurred framed certificate or diploma in the background.

Arul M. Chinnaiyan (Ph.D., M.D., 1999), the director of the Michigan Center for Translational Pathology and the S.P. Hicks Endowed Professor of Pathology, was awarded the 13th annual Harrington Prize for Innovation in Medicine. The award comes in recognition of his discovery of the TMPRSS2-ERG gene fusion, the most common genetic alteration in prostate cancer, which has become the basis for early diagnosis a driver of precision oncology treatments.

The Harrington Prize honors physician-scientists who have moved science forward with achievements notable for innovation, creativity, and potential for clinical application. Chinnaiyan is the first person from U-M to receive the award.

For more information, visit the University Record.

Tags:

  • Michigan Medicine
  • news
  • Pathology

Continue Reading